Medical News

RSS

Alimera to present Iluvien Phase 3 clinical trial data at AAO annual meeting

Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that data from its Phase 3 (FAME) clinical trials for Iluvien will be presented this month at the annual meeting of the American Academy of Ophthalmology (AAO) in Chicago.

12 Oct 2010

NCKU develops novel stem cell therapy for heart repair

Assistant Prof. Patrick C. H. Hsieh of Institute of Nanotechnology and Microsystems Engineering, College of Medicine, National Cheng Kung University (NCKU), Tainan, Taiwan, has led a research team of myocardial regeneration to conduct an experiment on pigs and has proved that by combining self-assembling peptide nanofiber hydrogel with autologous bone marrow stem cell, myocardial protection after acute myocardial infarction, vascular regeneration and heart functions can be improved.

12 Oct 2010

ACE educational program launched to promote awareness on anaphylaxis

Many of the approximately 1,500 deaths in the U.S. each year due to anaphylaxis, a sudden serious allergic reaction, could be prevented if more people knew the symptoms and the immediate treatment needed to survive.

12 Oct 2010

Engaging in healthy lifestyle can help women with family history control breast cancer risk

Having a family history of breast cancer can lead some women to wonder if the risk is out of their control. However, a study of more than 85,000 postmenopausal women, published in BioMed Central's open access journal Breast Cancer Research, observed that regular physical activity, maintaining a healthy weight, and drinking less alcohol lowers breast cancer risk for those with and without a family history of the disease.

12 Oct 2010

Adeona announces five scientific publications on Alzheimer's disease and cognitive decline

Adeona Pharmaceuticals, Inc., announced five scientific publications on the role of copper toxicity and zinc deficiency in Alzheimer's disease and cognitive decline.

12 Oct 2010

Parents rate research on safety of vaccines and medications given to children as most important

Each year, hundreds of millions of public and private dollars are spent on medical research to improve the health of children – yet parents have little input regarding how those dollars should be spent.

12 Oct 2010

Minnesota Foundation announces collaborative effort to improve health of underserved populations

In a report released this week, the Blue Cross and Blue Shield of Minnesota Foundation highlights the accomplishments of a collaborative effort to improve the health of underserved populations through the training and use of community health workers, titled Community health workers in Minnesota: Bridging barriers, expanding access, improving health.

12 Oct 2010

Integrated Research Network to analyze payor health policy for chronic pain medications

HealthCore's Integrated Research Network is enrolling family physicians, general practitioners, internists, neurologists, rheumatologists, endocrinologists, and pain management specialists in a first-of-its-kind study to analyze payor health policy for chronic pain medications.

12 Oct 2010

SynCardia Total Artificial Heart provides 'unexpected' 1,000 days of life

A 54-year-old Italian man has become the first patient to surpass 1,000 days of support with the SynCardia temporary Total Artificial Heart while waiting for a matching donor heart.

12 Oct 2010

Core administrative expenses of Medicaid plans decline

Core administrative expenses of Medicaid plans fell by 5.2% per member per month (PMPM) in 2009 versus a decline of 1.4% in 2008. After eliminating the effects of changes in product mix, PMPM costs declined by 5.8% in 2009 versus 2.7% in 2008.

12 Oct 2010

DHHS awards Medicare fraud contract to TerraMedica

Healthcare Technology firm TerraMedica LLC announced today that it has been awarded a contract by the U.S. Department of Health and Human Services (DHHS)/Office of the Assistant Secretary for Planning and Evaluation. TerraMedica will conduct an assessment of fraud, waste, and abuse in Medicare claims utilizing a pre-payment predictive scoring system.

12 Oct 2010

Twenty-two physical symptoms prevalent in all types of cancers

Twenty-two physical symptoms associated with cancer - symptoms often unrecognized and undertreated - are prevalent in all types of cancers regardless of whether the patient is newly diagnosed, undergoing treatment or is a cancer survivor, according to researchers from the Regenstrief Institute and the Indiana University schools of medicine and nursing.

12 Oct 2010

DSM, BRAIN announce strategic cooperation to develop water-soluble vitamins

DSM Nutritional Products GmbH, a subsidiary of the Dutch company Royal DSM N.V., the world's primary supplier of vitamins, carotenoids and fine chemicals and BRAIN AG, one of the leading European white biotechnology companies, announced a strategic cooperation in the biotechnological production of water-soluble vitamins.

12 Oct 2010

EMA approves TWYNSTA therapy that reduces BP in hypertensive patients

Boehringer Ingelheim announced today that the European Commission confirmed the positive opinion of the European Medicines Agency (EMA) approving TWYNSTA. TWYNSTA is indicated for the treatment of hypertension in adults whose blood pressure is not adequately controlled on amlodipine or as replacement therapy in adult patients receiving telmisartan and amlodipine from separate tablets containing the same component doses.

12 Oct 2010

Lundbeck, Merck announce commercialization agreement for SYCREST sublingual tablets

H. Lundbeck A/S (Lundbeck) and Merck, known outside the United States and Canada as MSD, today announced a commercialization agreement for SYCREST (asenapine) sublingual tablets (5 mg, 10 mg). Under the terms of the agreement, Lundbeck will pay an undisclosed fee as well as product supply payments in exchange for exclusive commercial rights to SYCREST in all markets outside the United States, China and Japan. Lundbeck expects to launch SYCREST in the European Union (EU), where it is already approved, at the beginning of 2011.

12 Oct 2010

Woman’s socioeconomic status impacts clinicians' decisions for contraception: Study

A woman's race/ethnicity and socioeconomic status impact whether health care providers recommend one of the most highly effective forms of contraception, a UCSF study confirms. The results also indicate that the interaction of both factors plays a role in clinicians' decisions.

12 Oct 2010

New excellence program established to recognize outstanding achievement in EMS profession

The National Association of Emergency Medical Technicians (NAEMT) and EMS World Magazine, in conjunction with the National Association of EMS Educators (NAEMSE) and the National EMS Management Association (NEMSMA), established the National EMS Awards of Excellence program to recognize outstanding achievement in the EMS profession.

12 Oct 2010

Teen Art Show shares teenagers' emotions in artistic fashion

With the help of the Child Life Program at St. Jude Children's Research Hospital, 22 new pieces of art were revealed from 19 talented adolescent patients during the Teen Art Show. The artwork is on display in a hospital hallway that was transformed permanently into the Teen Art Gallery.

12 Oct 2010

AACR announces recipients of Outstanding Investigator Award for Breast Cancer Research

The 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium will honor two leading breast cancer researchers during its meeting, which will be held Dec. 8-12 in the Henry B. Gonzales Convention Center, San Antonio, Texas. Klaus Pantel, M.D., Ph.D., is the recipient of the 2010 AACR Outstanding Investigator Award for Breast Cancer Research, funded by Susan G. Komen for the Cure.

12 Oct 2010

Targeted rehabilitation approach could improve physical capabilities in stroke patients

People who have become housebound after having a stroke are being invited to take part in a major new study that could help to put them back on the road to independence.

12 Oct 2010

Medical News

Alimera to present Iluvien Phase 3 clinical trial data at AAO annual meeting

NCKU develops novel stem cell therapy for heart repair

ACE educational program launched to promote awareness on anaphylaxis

Engaging in healthy lifestyle can help women with family history control breast cancer risk

Adeona announces five scientific publications on Alzheimer's disease and cognitive decline

Parents rate research on safety of vaccines and medications given to children as most important

Minnesota Foundation announces collaborative effort to improve health of underserved populations

Integrated Research Network to analyze payor health policy for chronic pain medications

SynCardia Total Artificial Heart provides 'unexpected' 1,000 days of life

Core administrative expenses of Medicaid plans decline

DHHS awards Medicare fraud contract to TerraMedica

Twenty-two physical symptoms prevalent in all types of cancers

DSM, BRAIN announce strategic cooperation to develop water-soluble vitamins

EMA approves TWYNSTA therapy that reduces BP in hypertensive patients

Lundbeck, Merck announce commercialization agreement for SYCREST sublingual tablets

Woman’s socioeconomic status impacts clinicians' decisions for contraception: Study

New excellence program established to recognize outstanding achievement in EMS profession

Teen Art Show shares teenagers' emotions in artistic fashion

AACR announces recipients of Outstanding Investigator Award for Breast Cancer Research

Targeted rehabilitation approach could improve physical capabilities in stroke patients

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News